Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01037088 · ClinicalTrials.gov registry record · Phase 1
Effects of Vaporized Marijuana on Neuropathic Pain
A Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT01037088: Completed Phase 1 study, sponsored by University of California, Davis.
NCT01037088 is a Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 44 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01037088, a Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study theorized that a low dose of vaporized cannabis could alleviate nerve injury pain.
Primary Outcome
The primary outcome variable, VAS Pain Intensity, was assessed by asking participants to indicate the intensity of their current pain on a 100-mm visual analog scale (VAS) between 0 (no pain) and 100 (worst possible pain).An assessment was performed before the administration of vaporized cannabis or placebo and hourly thereafter for six hours.
Interventions
- DRUG Cannabis
- DRUG Mild dose cannabis
- DRUG Low dose cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
What the finished NCT01037088 record still lists
NCT01037088 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower).
The record links to 0 conditions, and to 3 interventions - of which Cannabis is the first listed.
NCT01037088 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01037088 about?
NCT01037088 is a clinical study titled "Effects of Vaporized Marijuana on Neuropathic Pain". This study theorized that a low dose of vaporized cannabis could alleviate nerve injury pain.
What is the current status of trial NCT01037088?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2009-12. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01037088?
The interventions under investigation include: Cannabis (DRUG), Mild dose cannabis (DRUG), Low dose cannabis (DRUG).
Who is sponsoring clinical trial NCT01037088?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01037088's enrollment target sits among peer trials
44 1086th of 2000 higher than 901 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia